Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > Is Ifenprodil the next billion dollar cough drug?

View:

Post by XeniaTechie on Jan 12, 2023 1:25pm

Is Ifenprodil the next billion dollar cough drug?

Algernon Pharmaceuticals recently received FDA Orphan Drug Designation for Ifenprodil in IPF treatment & CEO Christopher Moreau shares an update for a new Phase 2B study slated to commence in July 2023 which will determine if its superior to current cough treatments.